Elixinol Global sees steady improvements in first quarter revenue as UK COVID restrictions ease and US stimulus packages take effect Its lead indicators for the current quarter are looking positive as the UK comes out of a hard lockdown and customers have started placing replenishment orders. It is well-funded with A$23.3 million to support acquisitive growth and sustain conditions in markets that are still COVID-affected Elixinol Global Ltd’s (ASX:EXL) (OTCMKTS:ELLXF) (FRA:E8M) group revenue steadily improved across the course of the March quarter as consumers recovered from Christmas trading periods, COVID-related restrictions started to ease in the UK and the impact of US stimulus packages took effect.